The premise of InvestorHub is this: you already have a message resonates with investors in a one-on-one scenario. Pitching in a room, across a table, or on a call 1:1 works well. The hard part is scaling that message. Enter InvestorHub. We don't just want to add
For the past five years, existing shareholders have been the primary source of buying pressure for public companies – and their influence has only strengthened over time. Recent data from a comprehensive analysis of over 1.2 million shareholders highlights a fundamental shift in the dynamics of shareholder engagement. Across both
Hey everyone – I’m Hannah! I joined InvestorHub three months ago, and it’s been an exciting journey so far! My first task here is taking over the community dinners, and it’s been such a great experience. In just the first few weeks, I’ve attended seven events and
I spoke with a few full time (aka professional) investors this week, and was reminded of a simple truth from long ago: Investing is a lonely job. I’m not talking about investment bankers who hunt in packs, or brokers and advisers parading as actual investors. I am talking about
After two tough years, the market is showing signs of life. But is this upswing here to stay, or just a temporary bounce? Dive into the latest data and see what it could mean for public companies on the ASX.
Two months ago, 70% of nano cap stocks were down. Since then, they’ve shown a sustained rebound, suggesting a potential return of investor confidence. Whether this signals a lasting trend remains to be seen, but cautious optimism is warranted.
It's a popular belief that investors only care about the dollars and cents, but for today’s article I am here with more InvestorHub data to show you that this is not the case. Ok - so some background information for context. 1. I run InvestorHub, a new
Being a public company is tough, but it might still beat staying private. Data shows public companies enjoy more capital, higher survival rates, and greater resilience than private firms.
In the intricate world of corporate governance, the role of a board member can be opaque for many, but not for Dagmar Parsons, a veteran non-executive director with over 15 years of experience on the boards of both public and private companies. Currently the chair of Advanced Braking Technology (ASX:
Features
Features
Insights
At InvestorHub, we recently analysed the registry data from over 100 public companies, spanning the past three months, to gain deeper insights into shareholder behaviour. What we discovered challenges a common assumption among many public companies: that the most effective way to build market momentum is by acquiring new shareholders.
Strategy
Since we first published this article, we have had to correct some original data. 56%, not 63%, of the source of buying volume over the prior three months had come from existing shareholders. The article has been edited accordingly, and you can read about our more comprehensive analysis here, which
Insights
Recent data from a study of over 350,000 investors shows that the majority of investors only trade once per year. This insight reveals a crucial aspect of investor behaviour: they tend to hold on to their investments and make fewer active decisions than commonly assumed. This tendency aligns with
Insights
When analysing shareholder data, the numbers can often paint a stark picture. Based on our recent analysis of over 350,000 shareholders, it becomes clear that many investors are facing a challenging climate. Here’s a detailed breakdown of where investors currently stand: * 28% of shareholders are in profit: Amidst
D2I
In last week's guest article from Rhori, we explored how shareholder loyalty programs could transform your company beyond a ticker on an exchange by building real, measurable conviction in your registry. The fact of that matter is your company won’t grow by constantly chasing new shareholders. InvestorHub
Strategy
How to build shareholder loyalty. If you want to be treated like a real company—not just another code—then it’s time to start treating your shareholders like actual people, not numbers. I’ve talked to hundreds of ASX leaders, and every single one says the same thing: “We
Features
Features
Strategy
Meet Dr Daniel Tillett. In late 2019, Dr Daniel Tillett, a biotech expert and investor, joined the board of Race Oncology. Despite expectations of a discount raise, he did something different: he invested at a premium. Since then, he’s raised $30m in a shareholder-driven round and never sold a